Transition in PSC (+IBD)
Please use this link: https://uke-de.zoom-x.de/s/64729932844
Speakers:
Deepak Joshi, Institute of Liver Studies, King’s College Hospital NHS Foundation, London, UK
Fabiana Zingone, Azienda Ospedale–Università di Padova, Italy
Chairs:
Ansgar W. Lohse, Universitätsklinikum Hamburg-Eppendorf, Germany
Agenda:
Transition is a very important topic for HCP especially for HCP dealing with chronic diseases which can have onset in children or young people. The transition is a progress of the young people getting adolescent, therefore something which has to be dealed with from every young people. But in young people this is even more complicate due to the chronic disease, the need for treatment and medical appointments and to “being different”. If the young people are not supported by family and HCP during this transition period and they have a bad transfer (= change of HCP from paediatric to adult services) the risk for non-adherence is very high. ERN Rare Liver are perfect places to discuss about and improve Transition since Adult HCP, paediatric HCP and patients are united in the ERN Rare Liver.
- Why is transition important in general for chronic diseases
- Why is ERN RL perfect platform to improve Transition, notification of the ERN Transition Working group and meeting as well as the youth panel
- What is known so far about negative impact on transition and transfer
- What we know from other diseases
- How can transition be improved, examples of transition programmes
- What are the differents between pediatric and adult PSC regarding diagnostic, presentation, treatment, comorbidities and outcome (case reports)
- What are particular aspects of transition in patients with PSC
- What can the paediatrician do, what can the adult HCP do?
- Summary and Take Home Message (“What can everybody do tomorrow in her/his clinic?)
Short bios:
Marianne Samyn is a Paediatric hepatologist working at King’s College hospital and clinical lead for the young adult liver clinic looking after young people aged 16-25 years. Research interest are in longterm outcomes of childhood liver diseases, autoimmune liver disease and adolescent care.
Fabiana Zingone is an Associate Professor at the Gastroenterology Unit of the Azienda Ospedale–Università di Padova, Italy. Her clinical and research work focuses on immune-mediated gastrointestinal disorders, with particular expertise in celiac disease and inflammatory bowel disease (IBD). Prof. Zingone is a board member of the Italian Society of Gastroenterology and Digestive Endoscopy (SIGE) and contributed to the recent Italian guidelines for the diagnosis and management of celiac disease. She is also the Treasurer of the International Society for the Study of Celiac Disease (ISSCD). She works at the Gastroenterology Unit, which hosts a tertiary referral center for inflammatory bowel disease. The center manages the diagnosis and follow-up of over 3,000 patients. Among her clinical responsibilities, she also leads the transition clinic, supporting adolescent patients as they move from pediatric to adult care.
Deepak Joshi is a transplant hepatologist with an interest in autoimmune liver disease. He is the clinical lead for HPB medicine and an advanced biliary endoscopist, specialising in paediatrics. He is a member of the Young Adult Liver service at King’s working in a multi-disciplinary team. He is a Reader in HPB medicine at King’s College London. He is a co-author of the book, Hepatology at a Glance. His current research interests include the management of biliary disease pre- and post – liver transplantation including the role of endoscopy. He is the current secretary of the (BASL) British Association for the Study of Liver.
We invite you to share any questions or topics you’d like to see addressed in our upcoming webinar. Submit your questions here: https://ec.europa.eu/eusurvey/runner/f92346c1-f28b-f1b1-cfce-e980c347bb0b